PFG Investments LLC Raises Stock Holdings in UnitedHealth Group Incorporated $UNH

PFG Investments LLC lifted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 36.1% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 11,793 shares of the healthcare conglomerate’s stock after acquiring an additional 3,127 shares during the quarter. PFG Investments LLC’s holdings in UnitedHealth Group were worth $3,679,000 at the end of the most recent quarter.

Several other large investors have also recently made changes to their positions in the business. Bayforest Capital Ltd increased its holdings in UnitedHealth Group by 685.7% during the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after buying an additional 48 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd increased its stake in shares of UnitedHealth Group by 416.7% during the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock worth $32,000 after purchasing an additional 50 shares during the last quarter. IAG Wealth Partners LLC purchased a new stake in shares of UnitedHealth Group during the 1st quarter worth approximately $42,000. O Brien Wealth Partners LLC increased its position in UnitedHealth Group by 74.0% in the first quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate’s stock worth $46,000 after buying an additional 37 shares during the last quarter. Finally, Kentucky Trust Co raised its stake in shares of UnitedHealth Group by 138.5% in the first quarter. Kentucky Trust Co now owns 93 shares of the healthcare conglomerate’s stock valued at $49,000 after buying an additional 54 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on the company. Robert W. Baird reissued an “underperform” rating and issued a $198.00 price objective (down previously from $312.00) on shares of UnitedHealth Group in a report on Thursday, July 31st. Baird R W lowered shares of UnitedHealth Group from a “hold” rating to a “strong sell” rating in a research report on Thursday, July 31st. Truist Financial boosted their target price on shares of UnitedHealth Group from $310.00 to $365.00 and gave the company a “buy” rating in a report on Tuesday, September 9th. Oppenheimer lowered their target price on shares of UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating on the stock in a report on Wednesday, July 30th. Finally, Morgan Stanley lifted their price target on UnitedHealth Group from $325.00 to $395.00 and gave the company an “overweight” rating in a research report on Friday, September 12th. Sixteen equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and an average target price of $358.95.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock opened at $345.11 on Wednesday. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73. The stock has a market capitalization of $312.56 billion, a price-to-earnings ratio of 14.95, a price-to-earnings-growth ratio of 2.25 and a beta of 0.45. The company has a fifty day moving average of $303.65 and a 200-day moving average of $357.64. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business had revenue of $111.62 billion for the quarter, compared to analysts’ expectations of $111.75 billion. During the same quarter in the previous year, the company earned $6.80 earnings per share. The business’s quarterly revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were paid a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.6%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group’s dividend payout ratio is 38.30%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.